Selective NF-κB inhibition in this model decreased pro-inflammatory microglia markers (CD68, CD86, and iNOS), suggesting a direct role of NF-κB in ALS pathogenesis [40]. Here, NFKB1 is linked to amyotrophic lateral sclerosis.